Dietary supplement use and prostate cancer risk in the carotene and retinol efficacy trial

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 8, 2009, Pages 2202-2206

  Neuhouser, Marian L ^a   Barnett, Matt J ^a   Kristal, Alan R ^a,b   Ambrosone, Christine B ^d   King, Irena B ^a   Thornquist, Mark ^a   Goodman, Gary G ^a,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SWEDISH MEDICAL CENTER   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; PLACEBO; RETINOL PALMITATE;

ADULT; ARTICLE; CANCER PREVENTION; CANCER RISK; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DOUBLE BLIND PROCEDURE; FAMILY HISTORY; HUMAN; LIFESTYLE; LUNG CANCER; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; CAROTENOIDS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RISK FACTORS; SMOKING; VITAMIN A;

EID: 68949105642     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0013     Document Type: Article

References (23)

1. White E, Patterson RE, Kristal AR, et al. VITamins And Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol 2004;159:83-93.
2. Slesinski MJ, Subar AF, Kahle LL. Trends in use of vitamin and mineral supplements in the US. J Am Diet Assoc 1995;95:921-3.
3. Neuhouser ML. Dietary supplement use by American women: challenges in assessing patterns of use, motives and costs. J Nutr 2003; 133:1992-6S.
4. Ervin RB, Wright JD, Kennedy-Stephenson JJ. Use of dietary supplements in the United States, 1988-1994. Vital Health Stat 1999;244:1-14.
5. Neuhouser ML, Patterson RE, Levy L. Motivations for using vitamin supplements. J Am Diet Assoc 1999;99:851-4.
6. Satia-Abouta J, Kristal AR, Patterson RE, Littman AJ, Stratton KL, White E. Dietary supplement use and medical conditions-the VITAL study. Am J Prev Med 2003;24:43-51.
7. Stevens VL, McCullough ML, Diver WR, et al. Use of multivitamins and prostate cancer mortality in a large cohort of US men. Cancer Causes Control 2005;16:643-50.
8. Lawson KA, Wright ME, Subar AF, et al. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst 2007;99.
9. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers. The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301: 39-51.
10. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of β carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
11. Omenn GS, Goodman GE, Thornquist MD, et al. The β-Carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res 1994;54:2038-43s.
12. Thornquist MD, Omenn GS, Goodman GE, et al. Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET). Control Clin Trials 1993;14:308-24.
13. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996;88:1550-9.
14. Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 2004; 160:339-49.
15. Neuhouser ML, Barnett MJ, Kristal AR, et al. (n-6) PUFA increase and dairy foods decrease prostate cancer risk in heavy smokers. J Nutr 2007;137:1821-7.
16. Ambrosone CB, Ahn J, Schoenenberger V. Antioxidant supplements, genetics and chemotherapy outcomes. Curr Cancer Ther Rev 2005;1: 251-8.
17. Bairati I, Meyer F, Gelinas M, et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst 2005;97:481-8.
18. Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-6.
19. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. Incidence of cancer and mortality following α-tocopherol and β-carotene supplementation. A postintervention follow-up. JAMA 2003; 290:476-85.
20. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002;94:981-90.
21. Gong Z, Neuhouser ML, Goodman PJ, et al. Obesity, diabetes, and risk of prostate cancer: results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev 2006;15:1977-83.
22. Neuhouser ML, Tinker L, Shaw PA, et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. Am J Epidemiol 2008;167:1247-59.
23. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297:2351-9.